Pharmacokinetics of H3B-6545 in patients with locally advanced or metastatic estrogen receptor-positive HER2 negative breast cancer (ER+ and HER2-BC)

被引：0
|
作者：
Majid, Oneeb [1 ]
Xiao, Jianjun Alan [2 ]
Sahmoud, Tarek [2 ]
Yasuda, Sanae [3 ]
Cantagallo, Lisa [2 ]
Hamilton, Erika P. [4 ]
Pluard, Timothy [5 ]
Juric, Dejan [6 ]
Gualberto, Antonio [2 ]
Husseiin, Ziad [1 ]
机构：
[1] Eisai, Hatfield, Herts, England
[2] H3 Biomed, Cambridge, MA USA
[3] Eisai Inc, Woodcliff Lake, NJ USA
[4] Sarah Cannon Res Inst, Nashville, TN USA
[5] St Lukes Canc Inst, Kansas City, MO USA
[6] Massachusetts Gen Hosp, Boston, MA 02114 USA
来源：
CANCER RESEARCH | 2021年 / 81卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
PS12-15
引用
收藏
页数：1
相关论文
共 50 条
  • [41] ELECTRA: An open-label, multicenter, phase 1b/2 study of elacestrant in combination with abemaciclib in patients with brain metastasis from estrogen receptor-positive (ER+), HER2-negative (HER2-) breast cancer (BC)
    Hamilton, Erika
    Kim, Sung-Bae
    Awada, Ahmad
    Lin, Nancy
    Zuefle, Sebastian
    Scartoni, Simona
    Vallespir, Bartomeu Piza
    Theall, Kathy Puyana
    Ibrahim, Nuhad
    ONCOLOGY RESEARCH AND TREATMENT, 2024, 47 : 30 - 31
  • [42] Exposureresponse analyses of GO39932: a Phase Ia/b study of giredestrant in estrogen receptor-positive, HER2negative, locally advanced or metastatic breast cancer
    Jhaveri, Komal
    Lien, Yi Ting
    Turner, Nicholas
    Lim, Elgene
    Cannon, Maureen
    Anziano, Richard
    Langenhorst, Jurgen
    Yoshida, Kenta
    Malhi, Vikram
    Gates, Mary
    Eng-Wong, Jennifer
    Li, Chunze
    Shah, Mona
    Perez-Moreno, Pablo
    Yu, Jiajie
    Bardia, Aditya
    CANCER RESEARCH, 2024, 84 (09)
  • [43] FDA Approval: Palbociclib for the Treatment of Postmenopausal Patients with Estrogen Receptor-Positive, HER2-Negative Metastatic Breast Cancer
    Beaver, Julia A.
    Amiri-Kordestani, Laleh
    Charlab, Rosane
    Chen, Wei
    Palmby, Todd
    Tilley, Amy
    Zirkelbach, Jeanne Fourie
    Yu, Jingyu
    Liu, Qi
    Zhao, Liang
    Crich, Joyce
    Chen, Xiao Hong
    Hughes, Minerva
    Bloomquist, Erik
    Tang, Shenghui
    Sridhara, Rajeshwari
    Kluetz, Paul G.
    Kim, Geoffrey
    Ibrahim, Amna
    Pazdur, Richard
    Cortazar, Patricia
    CLINICAL CANCER RESEARCH, 2015, 21 (21) : 4760 - 4766
  • [44] Fluoroestradiol (FES) and Fluorodeoxyglucose (FDG) PET imaging in patients with ER+, HER2-positive or HER2-negative metastatic breast cancer
    Hunter, Natasha B.
    Peterson, Lanell M.
    Specht, Jennifer M.
    Mankoff, David A.
    Muzi, Mark
    Chen, Delphine L.
    Gwin, William R.
    Vinayak, Shaveta
    Davidson, Nancy E.
    Linden, Hannah M.
    BREAST CANCER RESEARCH, 2025, 27 (01)
  • [45] Safety and activity of single-agent giredestrant (GDC-9545) from a phase Ia/b study in patients (pts) with estrogen receptor-positive (ER+), HER2-negative locally advanced/metastatic breast cancer (LA/mBC).
    Jhaveri, Komal L.
    Boni, Valentina
    Sohn, Joohyuk
    Villanueva-Vasquez, Rafael
    Bardia, Aditya
    Schmid, Peter
    Lim, Elgene
    Patel, Jaymin M.
    Alejandro Perez-Fidalgo, Jose
    Loi, Sherene
    Im, Seock-Ah
    Kshirsagar, Smita
    Gates, Mary R.
    Bond, John
    Eng-Wong, Jennifer
    Chang, Ching-Wei
    Turner, Nicholas C.
    Lopez Miranda, Elena
    Garcia-Estevez, Laura
    Bellet, Meritxell
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [46] Stromal Tumor-Infiltrating Lymphocytes in Hormone Receptor-Positive/HER2 Negative Metastatic Breast Cancer
    Pabba, Anirudh
    Zels, Gitte
    De Schepper, Maxim
    Geukens, Tatjana
    Van Baelen, Karen
    Maetens, Marion
    Leduc, Sophia
    Nguyen, Ha-Linh
    Mahdami, Amena
    Van Cauwenberge, Josephine
    Borremans, Kristien
    Izci, Hava
    Hatse, Sigrid
    Neven, Patrick
    Wildiers, Hans
    Biganzoli, Elia
    van den Bogaert, Wouter
    Richard, Francois
    Floris, Giuseppe
    Desmedt, Christine
    MODERN PATHOLOGY, 2025, 38 (02)
  • [47] The efficacy and safety of enzalutamide with trastuzumab in patients with HER2+ and androgen receptor-positive metastatic or locally advanced breast cancer
    Andrew Wardley
    Javier Cortes
    Louise Provencher
    Kathy Miller
    A. Jo Chien
    Hope S. Rugo
    Joyce Steinberg
    Jennifer Sugg
    Iulia C. Tudor
    Manon Huizing
    Robyn Young
    Vandana Abramson
    Ron Bose
    Lowell Hart
    Stephen Chan
    David Cameron
    Gail S. Wright
    Marie-Pascale Graas
    Patrick Neven
    Andrea Rocca
    Stefania Russo
    Ian E. Krop
    Breast Cancer Research and Treatment, 2021, 187 : 155 - 165
  • [48] The efficacy and safety of enzalutamide with trastuzumab in patients with HER2+and androgen receptor-positive metastatic or locally advanced breast cancer
    Wardley, Andrew
    Cortes, Javier
    Provencher, Louise
    Miller, Kathy
    Chien, A. Jo
    Rugo, Hope S.
    Steinberg, Joyce
    Sugg, Jennifer
    Tudor, Iulia C.
    Huizing, Manon
    Young, Robyn
    Abramson, Vandana
    Bose, Ron
    Hart, Lowell
    Chan, Stephen
    Cameron, David
    Wright, Gail S.
    Graas, Marie-Pascale
    Neven, Patrick
    Rocca, Andrea
    Russo, Stefania
    Krop, Ian E.
    BREAST CANCER RESEARCH AND TREATMENT, 2021, 187 (01) : 155 - 165
  • [49] ELECTRA: An open-label, multicenter, phase 1b/2 study of elacestrant in combination with abemaciclib in patients with brain metastasis (mets) from estrogen receptor-positive (ER+), HER2-negative (HER2-) breast cancer (BC)
    Ibrahim, Nuhad
    Kim, Sung-Bae
    Lin, Nancy
    Awada, Ahmad
    Gil, Eva Ciruelos
    Tonini, Giulia
    Vallespir, Bartomeu Piza
    Theall, Kathy Puvana
    Hamilton, Erika
    CANCER RESEARCH, 2024, 84 (09)
  • [50] The Genomic Landscape of ER Positive, HER2 Negative Breast Cancer
    Ramakrishna, M.
    Martin, S.
    Campbell, P. J.
    Futreal, P. A.
    Stratton, M. R.
    EUROPEAN JOURNAL OF CANCER, 2012, 48 : S132 - S132
12345